The Relationship between Hypomagnesemia, Metformin Therapy and Cardiovascular Disease Complicating Type 2 Diabetes: The Fremantle Diabetes Study
Table 1
Baseline characteristics of patients by blood glucose-lowering therapy including variables relevant to magnesium homoeostasis.
Data are percentages, mean±SD, geometric mean (SD range) or median [inter-quartile range].
a<0.05 vs diet alone; b<0.05 vs metformin alone; c<0.05 vs sulfonylurea alone, unadjusted for multiple comparisons.